Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
63.73%
Change (1 year)
Categories
Immunovant (IMVT) - P/B ratio
P/B ratio as of May 2024 : 6.29
According to Immunovant's latest financial reports the company has a price-to-book ratio of 6.29.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Immunovant - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.97 | 62.24% |
| 2022-12-31 | 5.53 | 185.08% |
| 2021-12-31 | 1.94 | -82.23% |
| 2020-12-31 | 10.9 | 40.8% |
| 2019-12-31 | 7.75 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.70 | -56.97% | 🇺🇸 USA |